catechin has been researched along with chiniofon in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avramovich-Tirosh, Y; Fridkin, M; Mandel, S; Mit, T; Reznichenko, L; Weinreb, O; Youdim, MB; Zheng, H | 1 |
| Amit, T; Avramovich-Tirosh, Y; Mandel, S; Youdim, MB | 1 |
1 review(s) available for catechin and chiniofon
| Article | Year |
|---|---|
Targeting multiple Alzheimer's disease etiologies with multimodal neuroprotective and neurorestorative iron chelators.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Brain; Catechin; Cell Cycle; Humans; Hydroxyquinolines; Iron; Iron Chelating Agents; Neurodegenerative Diseases; Neuroprotective Agents; PC12 Cells; Piperazines; Rats | 2008 |
1 other study(ies) available for catechin and chiniofon
| Article | Year |
|---|---|
Neurorescue activity, APP regulation and amyloid-beta peptide reduction by novel multi-functional brain permeable iron- chelating- antioxidants, M-30 and green tea polyphenol, EGCG.
Topics: Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Antioxidants; Apoptosis; Catechin; Cell Line, Tumor; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Hydroxyquinolines; Mice; Mice, Inbred C57BL; Models, Biological; Neuroblastoma | 2007 |